Should advanced donor age be a deterrent in the utilization of grafts from donation after cardiac death in deceased donor liver transplantation? The Toronto experience.

Authors:
Ray S; Shwaartz C; Sayed BA; Sapisochin G; Ghanekar A and 9 more

Journal:
Can J Surg

Publication Year: 2023

DOI:
10.1503/cjs.001123

PMCID:
PMC10699285

PMID:
38016726

Journal Information

Full Title: Can J Surg

Abbreviation: Can J Surg

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: General Surgery

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests: G. Sapisochin has received consulting fees from AstraZeneca, Roche, Chiesi Farmaceutici, HepaRegeniX and Novartis and a grant from Roche, all unrelated to the current study. C. Tsien has received consulting fees from Paladin Labs and speaker fees from Lupin Pharma Canada, unrelated to the current study. No other competing interests were declared."

Evidence found in paper:

"Funding: This work was supported by the Trillium Gift of Life Network (Ontario Health) [2016-21], Toronto, Ontario. The researchers’ interpretations and statements in this publication are those of the researchers only and not those of the Trillium Gift of Life Network (Ontario Health)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025